Anuh Pharma Limited (NSE:ANUHPHR)
India · Delayed Price · Currency is INR 81.94
-0.22 (-0.27%)
Nov 6, 2026, 3:29 PM IST
Anuh Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 8,285 | 6,727 | 7,459 | 12,308 | 3,990 | 4,307 | |
Market Cap Growth | -5.72% | -9.81% | -39.39% | 208.46% | -7.36% | -4.82% |
Enterprise Value | 7,503 | 6,598 | 7,081 | 11,824 | 3,486 | 4,209 |
Last Close Price | 81.55 | 65.75 | 71.96 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 17.20 | 16.39 | 15.75 | 20.49 | 11.03 | 14.09 |
PS Ratio | 1.07 | 0.87 | 1.13 | 1.90 | 0.76 | 0.89 |
PB Ratio | 2.30 | 1.91 | 2.29 | 4.23 | 1.65 | 2.02 |
P/TBV Ratio | 2.30 | 1.91 | 2.29 | 4.23 | 1.66 | 2.02 |
P/FCF Ratio | 18.38 | - | 43.93 | 155.62 | 7.62 | 15.81 |
P/OCF Ratio | 16.42 | - | 20.09 | 95.22 | 7.40 | 14.92 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.96 | 0.86 | 1.07 | 1.83 | 0.66 | 0.87 |
EV/EBITDA Ratio | 9.66 | 9.80 | 11.21 | 15.78 | 6.56 | 8.74 |
EV/EBIT Ratio | 11.14 | 11.69 | 12.89 | 17.68 | 7.97 | 11.52 |
EV/FCF Ratio | 16.65 | - | 41.71 | 149.51 | 6.66 | 15.45 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.05 | 0 | 0.03 | 0.01 | 0.00 | 0.02 |
Debt / EBITDA Ratio | 0.25 | 0.00 | 0.17 | 0.04 | 0.02 | 0.09 |
Debt / FCF Ratio | 0.43 | - | 0.64 | 0.34 | 0.02 | 0.16 |
Net Debt / Equity Ratio | -0.22 | -0.15 | -0.19 | -0.20 | -0.22 | -0.10 |
Net Debt / EBITDA Ratio | -1.01 | -0.78 | -0.99 | -0.79 | -0.98 | -0.44 |
Net Debt / FCF Ratio | -1.73 | 4.86 | -3.68 | -7.53 | -1.00 | -0.77 |
Asset Turnover | 1.46 | 1.45 | 1.39 | 1.52 | 1.40 | 1.43 |
Inventory Turnover | 4.11 | 5.48 | 6.76 | 6.64 | 5.34 | 4.72 |
Quick Ratio | 1.50 | 1.48 | 1.68 | 1.69 | 1.42 | 1.23 |
Current Ratio | 2.43 | 2.22 | 2.11 | 2.22 | 1.91 | 1.98 |
Return on Equity (ROE) | 13.91% | 12.10% | 15.34% | 22.56% | 15.90% | 15.11% |
Return on Assets (ROA) | 7.92% | 6.63% | 7.21% | 9.83% | 7.27% | 6.72% |
Return on Invested Capital (ROIC) | 16.95% | 15.19% | 17.23% | 24.38% | 17.46% | 14.87% |
Return on Capital Employed (ROCE) | 18.60% | 15.90% | 16.70% | 22.80% | 17.90% | 16.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 5.81% | 6.10% | 6.35% | 4.88% | 9.07% | 7.10% |
FCF Yield | 5.44% | -1.62% | 2.28% | 0.64% | 13.12% | 6.33% |
Dividend Yield | 1.83% | 2.23% | 2.02% | 1.02% | 2.51% | 2.04% |
Payout Ratio | 30.98% | 36.47% | 26.45% | 16.69% | 24.18% | 24.73% |
Buyback Yield / Dilution | -0.10% | -100.00% | 50.00% | - | - | - |
Total Shareholder Return | 1.73% | -97.77% | 52.02% | 1.02% | 2.51% | 2.04% |